Alert Launch Top Up Investment on SyndicateRoom

Alert Launch Top Up Investment on SyndicateRoom

We are excited to announce the launch of a top-up to our funding round on SyndicateRoom.

Having already reached our minimum target of £700,000, we are now extending our round to top up with a further £300,000 to reach £1m but will accept over-funding up to a max of £1.2m via SyndicateRoom.

Initial funds are being spent on:

  • Material costs for making the devices, productisation, and working capital to assemble 25 sample units for field trials.
Additional funds will be predominantly used for:
  • Faster development of new models, sector-specific models and brand marketing.

The 'Asbestos ALERT' is the first known warning device capable of distinguishing between airborne asbestos and non-asbestos fibres in real-time. It's objective is to reduce the risk of prolonged exposure that can lead to diseases such as cancer, asbestosis, and mesothelioma.















Our patented technology works using laser light scattering patterns to identify fibres and then determine the change in angular alignment of individual airborne fibres under the influence of an applied magnetic field to distinguish asbestos from other non-asbestos fibres.

The Asbestos ALERT is currently the only device capable of making this distinction in real-time on site.

As a pre-revenue business, Alert Technology has an impressive line-up of over 850 potential customers waiting for commercialisation and field trials of the first model and was recently shortlisted to present as one of only 36 companies at the CleanTech Innovate at London's prestigious Royal Institution.

To learn more, please take a look at our funding page on SyndicateRoom.

We’d be delighted if you wanted to invest and join us on our exciting journey.

To set up a meeting or phone call to learn more, please contact us either via SyndicateRoom or directly.

Risk warning: Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. SyndicateRoom is targeted exclusively at sophisticated investors who understand these risks and make their own investment decisions.

Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status.

Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.

Please click here to read the full risk warning.

This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021). Investments can be made only on the basis of information provided in each respective investment opportunity.

Return to listings

British Lung Foundation


Previous Next